A citation-based method for searching scientific literature

Finlay Campbell, Brett Archer, Henry Laurenson-Schafer, Yuka Jinnai, Franck Konings, Neale Batra, Boris Pavlin, Katelijn Vandemaele, Maria D Van Kerkhove, Thibaut Jombart, Oliver Morgan, Olivier le Polain de Waroux. Euro Surveill 2021
Times Cited: 382







List of co-cited articles
568 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
Nicholas G Davies, Sam Abbott, Rosanna C Barnard, Christopher I Jarvis, Adam J Kucharski, James D Munday, Carl A B Pearson, Timothy W Russell, Damien C Tully, Alex D Washburne,[...]. Science 2021
31

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant.
Jamie Lopez Bernal, Nick Andrews, Charlotte Gower, Eileen Gallagher, Ruth Simmons, Simon Thelwall, Julia Stowe, Elise Tessier, Natalie Groves, Gavin Dabrera,[...]. N Engl J Med 2021
27

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
Erik Volz, Swapnil Mishra, Meera Chand, Jeffrey C Barrett, Robert Johnson, Lily Geidelberg, Wes R Hinsley, Daniel J Laydon, Gavin Dabrera, Áine O'Toole,[...]. Nature 2021
546
25


Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum.
Chang Liu, Helen M Ginn, Wanwisa Dejnirattisai, Piyada Supasa, Beibei Wang, Aekkachai Tuekprakhon, Rungtiwa Nutalai, Daming Zhou, Alexander J Mentzer, Yuguang Zhao,[...]. Cell 2021
398
17

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization.
Delphine Planas, David Veyer, Artem Baidaliuk, Isabelle Staropoli, Florence Guivel-Benhassine, Maaran Michael Rajah, Cyril Planchais, Françoise Porrot, Nicolas Robillard, Julien Puech,[...]. Nature 2021
17

Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil.
Nuno R Faria, Thomas A Mellan, Charles Whittaker, Ingra M Claro, Darlan da S Candido, Swapnil Mishra, Myuki A E Crispim, Flavia C S Sales, Iwona Hawryluk, John T McCrone,[...]. Science 2021
682
16

SARS-CoV-2 variants, spike mutations and immune escape.
William T Harvey, Alessandro M Carabelli, Ben Jackson, Ravindra K Gupta, Emma C Thomson, Ewan M Harrison, Catherine Ludden, Richard Reeve, Andrew Rambaut, Sharon J Peacock,[...]. Nat Rev Microbiol 2021
14

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology.
Andrew Rambaut, Edward C Holmes, Áine O'Toole, Verity Hill, John T McCrone, Christopher Ruis, Louis du Plessis, Oliver G Pybus. Nat Microbiol 2020
13

Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study.
Katherine A Twohig, Tommy Nyberg, Asad Zaidi, Simon Thelwall, Mary A Sinnathamby, Shirin Aliabadi, Shaun R Seaman, Ross J Harris, Russell Hope, Jamie Lopez-Bernal,[...]. Lancet Infect Dis 2022
306
13

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.
Pengfei Wang, Manoj S Nair, Lihong Liu, Sho Iketani, Yang Luo, Yicheng Guo, Maple Wang, Jian Yu, Baoshan Zhang, Peter D Kwong,[...]. Nature 2021
12


Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Piyada Supasa, Daming Zhou, Wanwisa Dejnirattisai, Chang Liu, Alexander J Mentzer, Helen M Ginn, Yuguang Zhao, Helen M E Duyvesteyn, Rungtiwa Nutalai, Aekkachai Tuekprakhon,[...]. Cell 2021
287
11

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
Laith J Abu-Raddad, Hiam Chemaitelly, Adeel A Butt. N Engl J Med 2021
542
11

Detection of a SARS-CoV-2 variant of concern in South Africa.
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, Arash Iranzadeh, Vagner Fonseca, Jennifer Giandhari, Deelan Doolabh, Sureshnee Pillay, Emmanuel James San, Nokukhanya Msomi,[...]. Nature 2021
799
11

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.
Nicholas G Davies, Christopher I Jarvis, W John Edmunds, Nicholas P Jewell, Karla Diaz-Ordaz, Ruth H Keogh. Nature 2021
519
11

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera.
Daming Zhou, Wanwisa Dejnirattisai, Piyada Supasa, Chang Liu, Alexander J Mentzer, Helen M Ginn, Yuguang Zhao, Helen M E Duyvesteyn, Aekkachai Tuekprakhon, Rungtiwa Nutalai,[...]. Cell 2021
599
11

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Markus Hoffmann, Prerna Arora, Rüdiger Groß, Alina Seidel, Bojan F Hörnich, Alexander S Hahn, Nadine Krüger, Luise Graichen, Heike Hofmann-Winkler, Amy Kempf,[...]. Cell 2021
518
11

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK.
Koen B Pouwels, Emma Pritchard, Philippa C Matthews, Nicole Stoesser, David W Eyre, Karina-Doris Vihta, Thomas House, Jodie Hay, John I Bell, John N Newton,[...]. Nat Med 2021
244
11

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
David S Khoury, Deborah Cromer, Arnold Reynaldi, Timothy E Schlub, Adam K Wheatley, Jennifer A Juno, Kanta Subbarao, Stephen J Kent, James A Triccas, Miles P Davenport. Nat Med 2021
10

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
Sara Y Tartof, Jeff M Slezak, Heidi Fischer, Vennis Hong, Bradley K Ackerson, Omesh N Ranasinghe, Timothy B Frankland, Oluwaseye A Ogun, Joann M Zamparo, Sharon Gray,[...]. Lancet 2021
492
10

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Petra Mlcochova, Steven A Kemp, Mahesh Shanker Dhar, Guido Papa, Bo Meng, Isabella A T M Ferreira, Rawlings Datir, Dami A Collier, Anna Albecka, Sujeet Singh,[...]. Nature 2021
543
10

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India.
Sarah Cherian, Varsha Potdar, Santosh Jadhav, Pragya Yadav, Nivedita Gupta, Mousumi Das, Partha Rakshit, Sujeet Singh, Priya Abraham, Samiran Panda,[...]. Microorganisms 2021
324
10

Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta).
Sean Wei Xiang Ong, Calvin J Chiew, Li Wei Ang, Tze Minn Mak, Lin Cui, Matthias Paul H S Toh, Yi Ding Lim, Pei Hua Lee, Tau Hong Lee, Po Ying Chia,[...]. Clin Infect Dis 2022
183
10

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.
Allison J Greaney, Andrea N Loes, Katharine H D Crawford, Tyler N Starr, Keara D Malone, Helen Y Chu, Jesse D Bloom. Cell Host Microbe 2021
641
9

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
9

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Zijun Wang, Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, Christopher O Barnes, Shlomo Finkin, Dennis Schaefer-Babajew, Melissa Cipolla, Christian Gaebler, Jenna A Lieberman,[...]. Nature 2021
831
9

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.
Tyler N Starr, Allison J Greaney, Sarah K Hilton, Daniel Ellis, Katharine H D Crawford, Adam S Dingens, Mary Jane Navarro, John E Bowen, M Alejandra Tortorici, Alexandra C Walls,[...]. Cell 2020
959
9

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Fernando P Polack, Stephen J Thomas, Nicholas Kitchin, Judith Absalon, Alejandra Gurtman, Stephen Lockhart, John L Perez, Gonzalo Pérez Marc, Edson D Moreira, Cristiano Zerbini,[...]. N Engl J Med 2020
9

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Constantinos Kurt Wibmer, Frances Ayres, Tandile Hermanus, Mashudu Madzivhandila, Prudence Kgagudi, Brent Oosthuysen, Bronwen E Lambson, Tulio de Oliveira, Marion Vermeulen, Karin van der Berg,[...]. Nat Med 2021
732
9

Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Bo Meng, Steven A Kemp, Guido Papa, Rawlings Datir, Isabella A T M Ferreira, Sara Marelli, William T Harvey, Spyros Lytras, Ahmed Mohamed, Giulia Gallo,[...]. Cell Rep 2021
224
9

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
Shabir A Madhi, Vicky Baillie, Clare L Cutland, Merryn Voysey, Anthonet L Koen, Lee Fairlie, Sherman D Padayachee, Keertan Dheda, Shaun L Barnabas, Qasim E Bhorat,[...]. N Engl J Med 2021
694
8

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.
Daniel Wrapp, Nianshuang Wang, Kizzmekia S Corbett, Jory A Goldsmith, Ching-Lin Hsieh, Olubukola Abiona, Barney S Graham, Jason S McLellan. Science 2020
8

Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.
Alexandra C Walls, Young-Jun Park, M Alejandra Tortorici, Abigail Wall, Andrew T McGuire, David Veesler. Cell 2020
8

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Delphine Planas, Timothée Bruel, Ludivine Grzelak, Florence Guivel-Benhassine, Isabelle Staropoli, Françoise Porrot, Cyril Planchais, Julian Buchrieser, Maaran Michael Rajah, Elodie Bishop,[...]. Nat Med 2021
406
8

Antibody evasion by the P.1 strain of SARS-CoV-2.
Wanwisa Dejnirattisai, Daming Zhou, Piyada Supasa, Chang Liu, Alexander J Mentzer, Helen M Ginn, Yuguang Zhao, Helen M E Duyvesteyn, Aekkachai Tuekprakhon, Rungtiwa Nutalai,[...]. Cell 2021
319
8

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
Merryn Voysey, Sue Ann Costa Clemens, Shabir A Madhi, Lily Y Weckx, Pedro M Folegatti, Parvinder K Aley, Brian Angus, Vicky L Baillie, Shaun L Barnabas, Qasim E Bhorat,[...]. Lancet 2021
8

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
Xianding Deng, Miguel A Garcia-Knight, Mir M Khalid, Venice Servellita, Candace Wang, Mary Kate Morris, Alicia Sotomayor-González, Dustin R Glasner, Kevin R Reyes, Amelia S Gliwa,[...]. Cell 2021
274
8

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications.
Salim S Abdool Karim, Tulio de Oliveira. N Engl J Med 2021
366
8

Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2 - Guangdong Province, China, May-June 2021.
Meng Zhang, Jianpeng Xiao, Aiping Deng, Yingtao Zhang, Yali Zhuang, Ting Hu, Jiansen Li, Hongwei Tu, Bosheng Li, Yan Zhou,[...]. China CDC Wkly 2021
95
8

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study.
Po Ying Chia, Sean Wei Xiang Ong, Calvin J Chiew, Li Wei Ang, Jean-Marc Chavatte, Tze-Minn Mak, Lin Cui, Shirin Kalimuddin, Wan Ni Chia, Chee Wah Tan,[...]. Clin Microbiol Infect 2022
148
7

A pneumonia outbreak associated with a new coronavirus of probable bat origin.
Peng Zhou, Xing-Lou Yang, Xian-Guang Wang, Ben Hu, Lei Zhang, Wei Zhang, Hao-Rui Si, Yan Zhu, Bei Li, Chao-Lin Huang,[...]. Nature 2020
7

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity.
Qianqian Li, Jiajing Wu, Jianhui Nie, Li Zhang, Huan Hao, Shuo Liu, Chenyan Zhao, Qi Zhang, Huan Liu, Lingling Nie,[...]. Cell 2020
874
7

SARS-CoV-2 evolution during treatment of chronic infection.
Steven A Kemp, Dami A Collier, Rawlings P Datir, Isabella A T M Ferreira, Salma Gayed, Aminu Jahun, Myra Hosmillo, Chloe Rees-Spear, Petra Mlcochova, Ines Ushiro Lumb,[...]. Nature 2021
450
7

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Lindsey R Baden, Hana M El Sahly, Brandon Essink, Karen Kotloff, Sharon Frey, Rick Novak, David Diemert, Stephen A Spector, Nadine Rouphael, C Buddy Creech,[...]. N Engl J Med 2021
7

Virological assessment of hospitalized patients with COVID-2019.
Roman Wölfel, Victor M Corman, Wolfgang Guggemos, Michael Seilmaier, Sabine Zange, Marcel A Müller, Daniela Niemeyer, Terry C Jones, Patrick Vollmar, Camilla Rothe,[...]. Nature 2020
7

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization.
Zhuoming Liu, Laura A VanBlargan, Louis-Marie Bloyet, Paul W Rothlauf, Rita E Chen, Spencer Stumpf, Haiyan Zhao, John M Errico, Elitza S Theel, Mariel J Liebeskind,[...]. Cell Host Microbe 2021
454
7

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Qi Zhang, Xuanling Shi, Qisheng Wang, Linqi Zhang,[...]. Nature 2020
7

Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Eric J Haas, Frederick J Angulo, John M McLaughlin, Emilia Anis, Shepherd R Singer, Farid Khan, Nati Brooks, Meir Smaja, Gabriel Mircus, Kaijie Pan,[...]. Lancet 2021
771
6

A new coronavirus associated with human respiratory disease in China.
Fan Wu, Su Zhao, Bin Yu, Yan-Mei Chen, Wen Wang, Zhi-Gang Song, Yi Hu, Zhao-Wu Tao, Jun-Hua Tian, Yuan-Yuan Pei,[...]. Nature 2020
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.